Abstract: The present invention provides a movable vehicle. The movable vehicle comprises a carrying mechanism and a holding mechanism connected to the carrying mechanism, and the bottom of the carrying mechanism is provided with wheels, wherein the movable vehicle further comprises a starting mechanism arranged on the holding mechanism, the starting mechanism comprising a starting unit, a power supply unit, and a controller. The starting unit is configured to be switchable between an initial position and a start position. The controller is configured to be electrically connectable to the power supply unit, wherein when the starting unit is in the start position, the starting unit is coupled to the controller to activate the electrical connection between the controller and the power supply unit, and when the starting unit is in the initial position, the starting unit is decoupled from the controller.

Abstract: The present invention provides a differential and a moveable power tool that has this differential. The differential comprises an input mechanism, an output gear, a first transmission component and a second transmission component. The input mechanism comprises a main input end and an auxiliary input end. When meshing of the output gear and a main input mechanism fails, the first transmission component and the second transmission component engage, and the second transmission component in said engaged state drives the first transmission component to rotate in a predetermined direction, so that the auxiliary input end inputs movement to the output gear. The differential provided by the present invention can guarantee the effectiveness and stability of movement transfer, and reduces the occurrence of slippage.

Abstract: Disclosed are antigen binding polypeptides and antigen binding polypeptide complexes (e.g., antibodies and antigen binding fragments thereof) that bind to HIV proteins and have certain structural features. Also disclosed are polynucleotides and vectors encoding such polypeptides and polypeptide complexes; host cells; chimeric antigen receptors (CARs); immune cells; pharmaceutical compositions and kits containing such polypeptides and polypeptide complexes; and methods of using such polypeptides and polypeptide complexes in HIV.

Abstract: Embodiments of the present disclosure relate to the field of media technologies, and disclose an encoding method and apparatus, and a decoding method and apparatus, to reduce a rendering loss caused by compression of probe data. The encoding method includes: first determining a target normalization combination of a probe data group, then normalizing the probe data group based on the target normalization combination to obtain a normalized probe data group, and encoding the normalized probe data group into a bitstream. The target normalization combination minimizes a rendering loss corresponding to the probe data group among a plurality of normalization combinations, and the target normalization combination includes a target normalization method and a target normalization parameter.

Abstract: An encoding method includes obtaining probe data, where the probe data corresponds to one or more probes in a three-dimensional (3D) scene, and the probe data is used by a second device to determine shading effect of an object in the 3D scene in a rendering process; performing data form conversion on the probe data to obtain intermediate data, where the data form conversion includes domain conversion; and encoding the intermediate data to obtain a corresponding bitstream.

Abstract: The technology of this application relates to a probe data processing method and a probe data encoding method, and an apparatus. The probe data processing method in this application includes obtaining a bitstream, parsing the bitstream to obtain first probe data in a current probe data group, where the first probe data corresponds to a non-linear domain signal, obtaining a conversion function parameter of the current probe data group, obtaining an inverse conversion function of the current probe data group based on the conversion function parameter of the current probe data group, and performing spatial inverse conversion on the first probe data according to the inverse conversion function to obtain second probe data in the current probe data group, where the second probe data corresponds to one or more probes in a three-dimensional scene, and the second probe data corresponds to a linear domain signal.

Abstract: Embodiments of this application provide a decoding method and an electronic device. The method includes: obtaining a bitstream that includes intermediate data encoded by a second device; decoding the bitstream to obtain the intermediate data; and performing data form conversion, including domain conversion, on the intermediate data to obtain probe data. The probe data corresponds to one or more probes in a three-dimensional scene and is for determining a shading effect of an object in the three-dimensional scene in a rendering process.

Abstract: The present invention provides a movable vehicle. The movable vehicle comprises a carrying mechanism and a holding mechanism connected to the carrying mechanism, and the bottom of the carrying mechanism is provided with wheels, wherein the movable vehicle further comprises a starting mechanism arranged on the holding mechanism, the starting mechanism comprising a starting unit, a power supply unit, and a controller. The starting unit is configured to be switchable between an initial position and a start position. The controller is configured to be electrically connectable to the power supply unit, wherein when the starting unit is in the start position, the starting unit is coupled to the controller to activate the electrical connection between the controller and the power supply unit, and when the starting unit is in the initial position, the starting unit is decoupled from the controller.

Abstract: Disclosed are antigen binding polypeptides and antigen binding polypeptide complexes (e.g., antibodies and antigen binding fragments thereof) having certain structural features. Also disclosed are polynucleotides and vectors encoding such polypeptides and polypeptide complexes; chimeric antigen receptors (CARs), cells, pharmaceutical compositions and kits containing such polypeptides and polypeptide complexes; and methods of using such polypeptides and polypeptide complexes.

Abstract: Disclosed are antigen binding polypeptides and antigen binding polypeptide complexes (e.g., antibodies and antigen binding fragments thereof) having certain structural features. Also disclosed are polynucleotides and vectors encoding such polypeptides and polypeptide complexes; host cells; chimeric antigen receptors (CARs); immune cells; pharmaceutical compositions and kits containing such polypeptides and polypeptide complexes; and methods of using such polypeptides and polypeptide complexes.

Abstract: Disclosed are antigen binding polypeptides and antigen binding polypeptide complexes (e.g., antibodies and antigen binding fragments thereof) having certain structural features. Also disclosed are polynucleotides and vectors encoding such polypeptides and polypeptide complexes; host cells, chimeric antigen receptors (CARs), immune cells, pharmaceutical compositions and kits containing such polypeptides and polypeptide complexes; and methods of using such polypeptides and polypeptide complexes.

Abstract: An electronic apparatus includes a casing, a vent structure on the casing, and an electronic device inside the casing. The vent structure is used for a unidirectional flow and includes a frame and a louver. The louver includes a sheet body and a shaft. The sheet body includes a bent portion, a first and a second portion which oppositely extend from the bent portion and bind together. The shaft passes through a through hole formed by the bent portion and is connected to the frame, so that the sheet body is rotatable. When the louver is located at a closed position, the sheet body covers at least a portion of an opening structure of the frame. The louver is structurally simple and can be made of light material, which is conducive to improving the rotation agility of the louver and reducing the noise probably produced when in operation.

Abstract: Anti-human CD52 antibodies and antigen-binding fragments thereof are provided. Also provided are isolated nucleic acids, recombinant vectors and host cells for making the antibodies and fragments. The antibodies and fragments can be used in therapeutic applications to treat, for example, autoimmune diseases, cancer, and graft rejection.

Abstract: Anti-human CD52 antibodies and antigen-binding fragments thereof are provided. Also provided are isolated nucleic acids, recombinant vectors and host cells for making the antibodies and fragments. The antibodies and fragments can be used in therapeutic applications to treat, for example, autoimmune diseases, cancer, and graft rejection.

Abstract: A electronic device includes a chassis, a panel, a cover and a security structure. The panel covers a side of the chassis. The cover covers another side of the chassis. The security structure includes a locking component, a positioning component and a linking shaft. The locking component is disposed on the panel and interfered with the chassis to lock the panel. The positioning component is disposed on the cover and interfered with the chassis to position the cover. The linking shaft is disposed between the locking component and the positioning component and stops the positioning component from being separated from the chassis. When a position of the locking component is adjusted to release the interference between the locking component and the chassis, the linking shaft is driven by the locking component to release the positioning component and move along a direction away the panel.

Abstract: A electronic device includes a chassis, a panel, a cover and a security structure. The panel covers a side of the chassis. The cover covers another side of the chassis. The security structure includes a locking component, a positioning component and a linking shaft. The locking component is disposed on the panel and interfered with the chassis to lock the panel. The positioning component is disposed on the cover and interfered with the chassis to position the cover. The linking shaft is disposed between the locking component and the positioning component and stops the positioning component from being separated from the chassis. When a position of the locking component is adjusted to release the interference between the locking component and the chassis, the linking shaft is driven by the locking component to release the positioning component and move along a direction away the panel.

Abstract: An electronic apparatus includes a casing, a vent structure on the casing, and an electronic device inside the casing. The vent structure is used for a unidirectional flow and includes a frame and a louver. The louver includes a sheet body and a shaft. The sheet body includes a bent portion, a first and a second portion which oppositely extend from the bent portion and bind together. The shaft passes through a through hole formed by the bent portion and is connected to the frame, so that the sheet body is rotatable. When the louver is located at a closed position, the sheet body covers at least a portion of an opening structure of the frame. The louver is structurally simple and can be made of light material, which is conducive to improving the rotation agility of the louver and reducing the noise probably produced when in operation.

Abstract: Anti-human CD52 antibodies and antigen-binding fragments thereof are provided. Also provided are isolated nucleic acids, recombinant vectors and host cells for making the antibodies and fragments. The antibodies and fragments can be used in therapeutic applications to treat, for example, autoimmune diseases, cancer, and graft rejection.

Abstract: Disclosed herein is a method of identifying a tumor biomarker. In one example, a tumor biomarker is identified by obtaining a peripheral biological fluid sample from a subject with a tumor as well as a tumor sample and an adjacent non-tumor sample from such subject. A protein expression profile is detected in the peripheral biological fluid sample, tumor sample and adjacent non-tumor sample. The protein expression profiles of the peripheral biological fluid sample, tumor sample and adjacent non-tumor sample are then compared, wherein an increase in expression of a specific protein in the tumor sample and peripheral biological fluid sample but not in the adjacent non-tumor sample indicates that the specific protein is a biomarker of the tumor. Also disclosed herein is a gene profiling signature that can be used to diagnosis a subject with renal cell carcinoma (RCC) or to identify agents with therapeutic potential to treat RCC. Thus, methods of diagnosing a subject with RCC are disclosed.

Abstract: Disclosed herein is a method of identifying a tumor biomarker. In one example, a tumor biomarker is identified by obtaining a peripheral biological fluid sample from a subject with a tumor as well as a tumor sample and an adjacent non-tumor sample from such subject. A protein expression profile is detected in the peripheral biological fluid sample, tumor sample and adjacent non-tumor sample. The protein expression profiles of the peripheral biological fluid sample, tumor sample and adjacent non-tumor sample are then compared, wherein an increase in expression of a specific protein in the tumor sample and peripheral biological fluid sample but not in the adjacent non-tumor sample indicates that the specific protein is a biomarker of the tumor. Also disclosed herein is a gene profiling signature that can be used to diagnosis a subject with renal cell carcinoma (RCC) or to identify agents with therapeutic potential to treat RCC. Thus, methods of diagnosing a subject with RCC are disclosed.